Aimee Smart is Vice President of Clinical Development and Regulatory Processes at Lung Biotechnology PBC and Lung Bioengineering Inc., subsidiaries of United Therapeutics Corporation. She leads a team of 60+ professionals across clinical development, regulatory affairs, quality, and more, and serves on United Therapeutics' executive leadership team. Aimee successfully restructured Lung Biotechnology and later led a turnaround at Lung Bioengineering. With over 20 years in biotech and pharma, she previously held regulatory roles at VIRxSYS, Human Genome Sciences, Nabi Biopharma, and Cato Research. She earned a B.S. in Microbiology from NC State (Outstanding Young Alumni) and an Executive MBA from the University of Maryland (Poets & Quants “Best & Brightest”). She also holds leadership coaching and regulatory certifications and serves on the NC State College of Sciences Foundation Board.